Elmar R. Burchardt
Corporate Officer/Principal bei University of Witten/Herdecke
Profil
Elmar R.
Burchardt is currently an Associate Professor at the University of Witten.
Previously, he held positions as the Chief Executive Officer & Director at TheraVitae, Inc., President, Chief Executive Officer & Director at Hemostemix, Inc., Medical Director at Miltenyi GmbH, Vice President-Medical Affairs at Vericel Corp., and Senior Research Group Leader at Bayer AG.
He obtained his graduate and doctorate degrees from Hannover Medical School.
Aktive Positionen von Elmar R. Burchardt
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Witten/Herdecke | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Elmar R. Burchardt
| Unternehmen | Position | Ende |
|---|---|---|
| HEMOSTEMIX INC. | Vorstandsvorsitzender | 25.01.2017 |
| VERICEL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 30.05.2010 |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Vorstandsvorsitzender | - |
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - |
| BAYER AG | Corporate Officer/Principal | - |
Ausbildung von Elmar R. Burchardt
| Hannover Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| BAYER AG | Health Technology |
| HEMOSTEMIX INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |